Chen, D.-F., Prasad, V. K., Broadwater, G., Clark, A., Rizzieri, D. A., Chao, N. J., & Reinsmoen, N. L. (2008). 16-OR: Relevance of inhibitory and activating KIR and HLA ligand on outcomes in reduced intensity haploidentical peripheral blood stem cell transplants. In Human Immunology (Vol. 69, pp. S8–S8). Elsevier BV. https://doi.org/10.1016/j.humimm.2008.08.018

Chen, Dong-Feng, Vinod K. Prasad, Gloria Broadwater, Adella Clark, David A. Rizzieri, Nelson J. Chao, and Nancy L. Reinsmoen. “16-OR: Relevance of inhibitory and activating KIR and HLA ligand on outcomes in reduced intensity haploidentical peripheral blood stem cell transplants.” In Human Immunology, 69:S8–S8. Elsevier BV, 2008. https://doi.org/10.1016/j.humimm.2008.08.018.

Chen D-F, Prasad VK, Broadwater G, Clark A, Rizzieri DA, Chao NJ, et al. 16-OR: Relevance of inhibitory and activating KIR and HLA ligand on outcomes in reduced intensity haploidentical peripheral blood stem cell transplants. In: Human Immunology. Elsevier BV; 2008. p. S8–S8.

Chen, Dong-Feng, et al. “16-OR: Relevance of inhibitory and activating KIR and HLA ligand on outcomes in reduced intensity haploidentical peripheral blood stem cell transplants.” Human Immunology, vol. 69, Elsevier BV, 2008, pp. S8–S8. Crossref, doi:10.1016/j.humimm.2008.08.018.

Chen D-F, Prasad VK, Broadwater G, Clark A, Rizzieri DA, Chao NJ, Reinsmoen NL. 16-OR: Relevance of inhibitory and activating KIR and HLA ligand on outcomes in reduced intensity haploidentical peripheral blood stem cell transplants. Human Immunology. Elsevier BV; 2008. p. S8–S8.